What 500 million data points can teach us about MSK

Clinical trials remain essential for advancing musculoskeletal care. But they take time, they’re often limited in size, and they don’t always reflect how treatment plays out in real life.

That’s where real-world evidence (RWE) changes the game. With the right data, at scale, we can better understand how patients respond to care over time not just in controlled conditions, but in their everyday routines.

Joint Academy provides one of the largest real-world MSK data sets in the world. And it’s already helping researchers, health systems, and industry partners accelerate discovery and refine treatment strategies.

What makes this data valuable:

• Large-scale, diverse cohorts
  With over 200,000 patients and growing, the database captures insights across ages, conditions, locations, and care types, all with detailed outcome tracking.
• High-frequency, patient-reported outcomes
  Daily engagement through the app creates a rich stream of patient-reported data, including pain levels, function, mobility, and adherence.
• Live access and real-time trends
  Through the Joint Academy Data Portal, research partners can explore data, run queries, and observe population shifts as they happen.

From data to discovery

When data is structured, continuous, and connected to clinical outcomes, it becomes a tool for discovery not just analysis. Whether you’re studying adherence, intervention impact, or unmet needs, the right data can unlock faster, more accurate answers.

Joint Academy is built on science, and designed to contribute to it.